Filana Therapeutics, Inc. (FLNA)
0.8201
-0.01
(-0.99%)
USD |
NASDAQ |
Sep 04, 16:00
0.8183
0.00 (0.00%)
After-Hours: 20:00
Filana Therapeutics SG&A Expense (TTM) : 30.32M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 30.32M |
| March 31, 2026 | 64.50M |
| December 31, 2025 | 68.80M |
| September 30, 2025 | 68.06M |
| June 30, 2025 | 73.10M |
| March 31, 2025 | 79.03M |
| December 31, 2024 | 71.81M |
| September 30, 2024 | 66.91M |
| June 30, 2024 | 58.24M |
| March 31, 2024 | 15.84M |
| December 31, 2023 | 16.53M |
| September 30, 2023 | 15.76M |
| June 30, 2023 | 14.30M |
| March 31, 2023 | 13.46M |
| December 31, 2022 | 11.99M |
| September 30, 2022 | 12.80M |
| June 30, 2022 | 11.70M |
| March 31, 2022 | 9.966M |
| December 31, 2021 | 8.055M |
| September 30, 2021 | 5.058M |
| June 30, 2021 | 4.384M |
| March 31, 2021 | 3.965M |
| December 31, 2020 | 3.739M |
| September 30, 2020 | 3.472M |
| June 30, 2020 | 3.265M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.292M |
| December 31, 2019 | 3.391M |
| September 30, 2019 | 3.301M |
| June 30, 2019 | 3.318M |
| March 31, 2019 | 3.471M |
| December 31, 2018 | 3.693M |
| September 30, 2018 | 3.824M |
| June 30, 2018 | 3.953M |
| March 31, 2018 | 4.058M |
| December 31, 2017 | 4.335M |
| September 30, 2017 | 4.664M |
| June 30, 2017 | 4.571M |
| March 31, 2017 | 4.923M |
| December 31, 2016 | 5.781M |
| September 30, 2016 | 5.487M |
| June 30, 2016 | 5.933M |
| March 31, 2016 | 5.879M |
| December 31, 2015 | 5.102M |
| September 30, 2015 | 5.247M |
| June 30, 2015 | 5.346M |
| March 31, 2015 | 5.267M |
| December 31, 2014 | 5.127M |
| September 30, 2014 | 5.258M |
| June 30, 2014 | 5.119M |
| March 31, 2014 | 4.936M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| CorMedix, Inc. | 138.00M |
| Eloxx Pharmaceuticals, Inc. | 6.133M |
| Cannabis Global, Inc. | 0.0299M |
| Breakthrough Chemistry, Inc. | 0.073M |
| BioStem Technologies, Inc. | 44.34M |